Transactions by TIBET RHODIOLA PHARM-A (600211) in the last 6 months

Announced 10/30/14

785.00M for Tibet Rhodiola Pharmaceutical Holding Company

Merger/Acquisition

Shenzhen Kangzhe Pharmaceutical Technology Development Co., Ltd. signed an agreement to acquire additional 17.97% stake in Tibet Rhodiola Pharmaceutical Holding Company (SHSE:600211) from Beijing New Phoenix Properties Development Limited, Tibet TongYing Investment Co., Ltd. and Tianjin Tongsheng Investment Co. Ltd. for approximately CNY 780 million in cash on October 29, 2014. The consideration is subject to adjustments. Kangzhe Pharmaceutical will acquire 13.73%, 3.09% ... and 1.14% stakes from Beijing New Phoenix Properties Development Limited, Tibet TongYing Investment Co., Ltd. and Tianjin Tongsheng Investment Co. Ltd. respectively. Shenzhen Kangzhe Pharmaceutical Technology Development will acquire 26.16 million shares at CNY 30 per share.
The shares to be transferred by Beijing New Phoenix Properties have been pledged by the in favour of a third party. Kangzhe Pharmaceutical shall provide a loan of CNY 170 million to Beijing New Phoenix Properties within three working days after the existing pledgee issues a written consent to the extent that Beijing New Phoenix Properties may make early repayment and the existing pledgee shall release the existing share pledge as soon as possible upon the receipt of such repayment and CNY 430 million shall be paid within three working days after Beijing New Phoenix Properties having pledged the shares in favour of Kangzhe Pharmaceuticals. Kangzhe Pharmaceutical shall pay 600 million to Beijing New Phoenix Properties Development Limited, CNY 135.09 million to Tibet TongYing and CNY 49.79 million to Tianjin Tongsheng Investment. In the event of termination, any consideration that has already been paid shall be refunded within two working days. The transaction shall be completed when Tibet Pharmaceuticals' shares are registered under the name of Shenzhen Kangzhe Pharmaceutical Technology Development Co., Ltd.Read More

600211's price was unchanged after the transaction was announced on 10/30/14.

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.